Reneural Therapeutics is a pharmaceutical startup focused on the treatment of neurological disorders currently seeking funding to advance its lead candidates into pre-clinical development.
Our model is to identify, acquire rights to, and accelerate the development and commercialisation of breakthrough therapeutics for the central nervous system. We have recently secured worldwide license terms with a publicly traded company for both a lead and backup compound.
Our world-class team of scientists, and pharmaceutical developers are dedicated to improving global health leveraging proven capabilities in identifying, acquiring, and accelerating assets through development and commercialisation.
We are bound by strict confidentiality obligations under our agreement with the licensor, therefore please contact us for more information.